PSA
37
2
SO
53
5
DRI
64
4
F
58
2
FTI
61
-2
ROK
47
-3
SJM
14
3
TGT
52
2
MSI
47
-2
EXR
26
2
PEG
50
4
MHK
50
2
NVDA
57
-2
DHI
40
3
VMC
59
2
RF
63
2
ADT
48
2
ETR
52
3
IBM
67
2
FITB
72
2
PSA
37
2
SO
53
5
DRI
64
4
F
58
2
FTI
61
-2
ROK
47
-3
SJM
14
3
TGT
52
2
MSI
47
-2
EXR
26
2
PEG
50
4
MHK
50
2
NVDA
57
-2
DHI
40
3
VMC
59
2
RF
63
2
ADT
48
2
ETR
52
3
IBM
67
2
FITB
72
2
Financhill
Back

F/m US Treasury 2 Year Note ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
57

UTWO
F/m US Treasury 2 Year Note ETF

Last Price:
$48.64
Seasonality Move:
-0.12%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
57
F/m US Treasury 2 Year Note ETF (UTWO) is a Buy

Is F/m US Treasury 2 Year Note ETF a Buy, Sell or Hold?

  • The current F/m US Treasury 2 Year Note ETF [UTWO] share price is $48.64. The Score for UTWO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • UTWO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UTWO Stock Price Chart

What is F/m US Treasury 2 Year Note ETF's stock price today?

  • The F/m US Treasury 2 Year Note ETF share price today is $48.64
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTWO is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

UTWO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12 Buy
Relative Strength Index (14 RSI): 56.81 Buy
Chaikin Money Flow: 87403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.53 - 48.65) Buy
Bollinger Bands (100): (48.46 - 48.62) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

UTWO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.62 Buy
20-day SMA: 48.59 Buy
50-day SMA: 48.59 Buy
200-day SMA: 48.45 Buy
8-day EMA: 34.79 Buy
20-day EMA: 19.15 Buy
50-day EMA: 8.82 Buy
200-day EMA: 2.37 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

F/m US Treasury 2 Year Note ETF Earnings Growth & UTWO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

F/m US Treasury 2 Year Note ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):